DocGo (DCGO) Competitors $1.39 -0.07 (-4.79%) Closing price 04:00 PM EasternExtended Trading$1.40 +0.01 (+0.65%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. FLGT, INNV, CSTL, LFMD, CELC, OMDA, FTRE, AUNA, TALK, and SBCShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Fulgent Genetics (FLGT), InnovAge (INNV), Castle Biosciences (CSTL), LifeMD (LFMD), Celcuity (CELC), Omada Health (OMDA), Fortrea (FTRE), Auna (AUNA), Talkspace (TALK), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry. DocGo vs. Its Competitors Fulgent Genetics InnovAge Castle Biosciences LifeMD Celcuity Omada Health Fortrea Auna Talkspace SBC Medical Group Fulgent Genetics (NASDAQ:FLGT) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Does the media prefer FLGT or DCGO? In the previous week, Fulgent Genetics had 2 more articles in the media than DocGo. MarketBeat recorded 3 mentions for Fulgent Genetics and 1 mentions for DocGo. DocGo's average media sentiment score of 1.89 beat Fulgent Genetics' score of 1.19 indicating that DocGo is being referred to more favorably in the news media. Company Overall Sentiment Fulgent Genetics Positive DocGo Very Positive Do analysts rate FLGT or DCGO? Fulgent Genetics presently has a consensus target price of $24.00, suggesting a potential upside of 32.82%. DocGo has a consensus target price of $3.56, suggesting a potential upside of 156.12%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is FLGT or DCGO more profitable? DocGo has a net margin of -0.12% compared to Fulgent Genetics' net margin of -13.94%. DocGo's return on equity of 2.52% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Fulgent Genetics-13.94% -2.19% -2.02% DocGo -0.12%2.52%1.70% Do insiders and institutionals hold more shares of FLGT or DCGO? 48.1% of Fulgent Genetics shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 33.1% of Fulgent Genetics shares are owned by insiders. Comparatively, 2.7% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, FLGT or DCGO? Fulgent Genetics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, DocGo has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Which has stronger valuation and earnings, FLGT or DCGO? DocGo has higher revenue and earnings than Fulgent Genetics. DocGo is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFulgent Genetics$283.47M1.94-$42.71M-$1.33-13.59DocGo$616.55M0.23$19.99M-$0.02-69.50 SummaryDocGo beats Fulgent Genetics on 10 of the 14 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$148.90M$7.11B$5.53B$9.30BDividend YieldN/A2.83%4.59%4.03%P/E Ratio24.3334.4428.5619.60Price / Sales0.2329.22359.9473.66Price / Cash3.4524.5224.7327.56Price / Book0.458.098.155.55Net Income$19.99M$236.06M$3.24B$257.73M7 Day Performance-10.32%-2.33%2.03%0.95%1 Month Performance-4.14%0.45%8.29%10.68%1 Year Performance-55.31%25.93%28.40%15.67% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.1981 of 5 stars$1.39-4.8%$3.56+156.1%-53.1%$148.90M$616.55M24.334,407Positive NewsFLGTFulgent Genetics4.0887 of 5 stars$19.29-3.8%$24.00+24.4%-8.7%$610.70M$283.47M-14.501,313Positive NewsINNVInnovAge1.0014 of 5 stars$4.17-6.5%$5.00+19.9%-24.4%$602.16M$763.85M-18.132,350Gap DownCSTLCastle Biosciences2.278 of 5 stars$19.46-4.1%$37.00+90.1%+5.1%$586.11M$332.07M-102.42540News CoveragePositive NewsLFMDLifeMD2.5236 of 5 stars$12.20-2.4%$12.00-1.6%+83.5%$568.09M$212.45M-35.88230Analyst ForecastCELCCelcuity2.3128 of 5 stars$13.34-3.3%$28.40+112.9%-22.6%$522.18MN/A-4.4040News CoverageOMDAOmada HealthN/A$18.67+0.2%$23.57+26.3%N/A$479.72MN/A0.00849Quiet Period ExpirationFTREFortrea3.7991 of 5 stars$4.45-14.8%$15.00+237.1%-80.7%$472.41M$2.70B-0.5115,500AUNAAuna3.2891 of 5 stars$6.25-1.3%$10.70+71.3%-18.1%$468.50M$1.17B10.7714,842TALKTalkspace3.8812 of 5 stars$2.65-4.3%$4.50+69.8%+20.1%$463.46M$187.59M132.57500News CoverageSBCSBC Medical GroupN/A$4.51+0.9%N/AN/A$463.14M$205.42M0.00N/A Related Companies and Tools Related Companies FLGT Alternatives INNV Alternatives CSTL Alternatives LFMD Alternatives CELC Alternatives OMDA Alternatives FTRE Alternatives AUNA Alternatives TALK Alternatives SBC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCGO Stock Alerts